« Back
Home /
Bevacizumab (anti-VEGF)

Bevacizumab (anti-VEGF)

Item no.	A2006-25mg
Manufacturer	Selleckchem
CASRN	216974-75-3
Amount	1mg x 25
Quantity options	1mg 1mg x 25 1mg x 5
Category	Oncology By Cell Type Carcinoma Cell Biology Cell Culture Cytokines Adenocarcinoma Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	rhuMab VEGF
Available
Storage Conditions	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Information	Bevacizumab (anti-VEGF, Avastin) is a humanized anti-VEGF monoclonal antibody which binds to and neutralizes all human VEGF-A isoforms and bioactive proteolytic fragments, MW:149 KD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg x 25

available

Delivery expected until 12/13/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail